Waystar Announces Pricing of Secondary Offering of Common Stock
Waystar (NASDAQ: WAY), a healthcare payments software provider, has announced the pricing of a secondary offering where existing shareholders will sell 18 million shares at $39.40 per share. The selling stockholders include investment funds from EQT AB, Bain Capital, LP, and Canada Pension Plan Investment Board.
The offering is expected to close around September 12, 2025, with J.P. Morgan acting as the underwriter. Importantly, Waystar will not receive any proceeds from this secondary offering as the company is not selling any shares directly.
Waystar (NASDAQ: WAY), fornitore di software per i pagamenti nel settore sanitario, ha comunicato il prezzo di un collocamento secondario in cui azionisti esistenti venderanno 18 milioni di azioni a 39,40 $ ciascuna. Tra i venditori figurano fondi di EQT AB, Bain Capital, LP e Canada Pension Plan Investment Board.
L'operazione dovrebbe essere conclusa intorno al 12 settembre 2025, con J.P. Morgan come sottoscrittore. È importante notare che Waystar non riceverà proventi da questo collocamento secondario, poiché la società non sta vendendo azioni direttamente.
Waystar (NASDAQ: WAY), proveedor de software para pagos en salud, ha anunciado el precio de una colocación secundaria en la que accionistas existentes venderán 18 millones de acciones a 39,40 $ por acción. Entre los vendedores se encuentran fondos de EQT AB, Bain Capital, LP y Canada Pension Plan Investment Board.
Se espera que la operación cierre alrededor del 12 de septiembre de 2025, con J.P. Morgan como colocador. Es importante destacar que Waystar no recibirá ingresos por esta colocación secundaria, ya que la compañía no está vendiendo acciones directamente.
Waystar (NASDAQ: WAY)는 헬스케어 결제 소프트웨어 제공업체로, 기존 주주들이 주당 39.40달러에 1,800만주를 판매하는 2차 공모의 가격을 발표했습니다. 매도 주주에는 EQT AB, Bain Capital, LP 및 Canada Pension Plan Investment Board의 투자 펀드가 포함됩니다.
이 거래는 2025년 9월 12일경 종료될 것으로 예상되며, 인수인은 J.P. Morgan입니다. 중요한 점은 Waystar는 직접 주식을 매도하지 않으므로 이번 2차 공모로부터 어떠한 수익도 받지 않는다는 것입니다.
Waystar (NASDAQ: WAY), fournisseur de logiciels de paiement pour la santé, a annoncé le prix d'une offre secondaire dans laquelle des actionnaires existants vendront 18 millions d'actions à 39,40 $ l'action. Les cédants incluent des fonds d'EQT AB, Bain Capital, LP et du Canada Pension Plan Investment Board.
L'opération devrait se clore aux alentours du 12 septembre 2025, avec J.P. Morgan en qualité de souscripteur. Il est important de noter que Waystar ne recevra aucun produit de cette offre secondaire, la société ne vendant pas d'actions elle-même.
Waystar (NASDAQ: WAY), ein Anbieter von Zahlungssoftware im Gesundheitswesen, hat die Preisfestsetzung einer Sekundärplatzierung bekanntgegeben, bei der bestehende Aktionäre 18 Millionen Aktien zu je 39,40 $ verkaufen werden. Zu den verkaufenden Anteilseignern gehören Investmentfonds von EQT AB, Bain Capital, LP und dem Canada Pension Plan Investment Board.
Der Abschluss der Transaktion wird voraussichtlich um den 12. September 2025 erfolgen; J.P. Morgan fungiert als Underwriter. Wichtig: Waystar selbst erhält aus dieser Sekundärplatzierung keine Erlöse, da das Unternehmen keine Aktien direkt verkauft.
- None.
- Large secondary offering of 18 million shares could create selling pressure
- Significant shareholders reducing their stake might signal reduced confidence
Insights
Major shareholders selling $709.2M worth of Waystar shares in secondary offering; no proceeds going to company.
This secondary offering announcement reveals significant insider selling from Waystar's major institutional shareholders. The 18 million shares being sold by EQT AB, Bain Capital, and Canada Pension Plan Investment Board at
Large secondary offerings like this typically signal that major early investors are looking to reduce their positions and realize returns. While this doesn't necessarily indicate negative company prospects, the market often interprets substantial insider selling as a potential lack of confidence in future growth or current valuation. The timing and size of this offering will likely create temporary selling pressure on WAY shares.
The involvement of J.P. Morgan as the sole underwriter suggests this is a well-coordinated, strategic exit rather than a rushed liquidation. With the offering expected to close around September 12th, investors should watch for potential short-term price volatility as the market absorbs this significant influx of shares. The fact that all three major investors are participating in the offering simultaneously rather than staggering their exits adds to the significance of this liquidity event.
J.P. Morgan is acting as the underwriter for the offering.
A registration statement on Form S-3 relating to these securities has been filed with the SEC and has become effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
The offering may be made only by means of a prospectus supplement and accompanying prospectus. Copies of the prospectus supplement and accompanying prospectus may be obtained by contacting: J.P. Morgan Securities LLC, Attention: c/o Broadridge Financial Solutions, 1155 Long Island Avenue,
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and are inherently subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks and uncertainties include, but are not limited to, risks and uncertainties associated with the consummation of the offering and other risks described in Waystar's Annual Report on Form 10-K for the year ended December 31, 2024 and any subsequent filings with the SEC. Except as required by law, Waystar has no obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the
Media Contact
Kristin Lee
kristin.lee@waystar.com
Investor Contact
investors@waystar.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-announces-pricing-of-secondary-offering-of-common-stock-302553889.html
SOURCE Waystar
FAQ
What is the price of Waystar's (WAY) secondary stock offering in September 2025?
Who are the selling stockholders in Waystar's secondary offering?
Will Waystar (WAY) receive any proceeds from the secondary offering?
When will Waystar's secondary stock offering close?
Who is the underwriter for Waystar's secondary offering?
